van der Kraaij A M, van Eijk H G, Koster J F
Department of Biochemistry, Erasmus University Rotterdam, The Netherlands.
Circulation. 1989 Jul;80(1):158-64. doi: 10.1161/01.cir.80.1.158.
In this study, we investigated the role of oxygen-derived free radicals and iron in mediating myocardial injury during ischemia and reperfusion. Iron is of special interest because it may enhance tissue injury during ischemia and reperfusion by catalyzing the formation of highly reactive hydroxyl radicals (by modified Haber-Weiss or Fenton reactions). Rat hearts, perfused by the Langendorff method, were subjected to global ischemia (15 minutes at 37 degrees C) and reperfusion. The effects of two iron chelators, 1,2-dimethyl-3-hydroxy-4-pyridone (L1) and 5-hydroxy-2-hydroxymethyl-4-pyrone (kojic acid), and one antioxidant, (+)-cyanidanol-3, on contractile function, coronary flow, lactate dehydrogenase release, and lactate production were studied. The combination of these iron chelators is of special importance because L1 is known to prevent lipid peroxidation, induced by ADP/Fe3+ and NADPH in microsomes, in contrast to kojic acid. We found significant protection of contractile function (apex displacement) during reperfusion with 50 microM L1 and 20 microM (+)-cyanidanol-3 (p less than 0.01, n = 6), whereas no protection was found with 50 microM kojic acid (n = 6). Measurements of lactate dehydrogenase release during reperfusion showed a protective pattern similar to that found for heart contractile function, although 50 microM kojic acid also showed a significantly lower lactate dehydrogenase release during the first 10 minutes of reperfusion. No differences in coronary resistance or lactate release were found between the various groups. Our findings indicate that iron and oxygen-derived free radicals are important in the pathogenesis of postischemic reperfusion injury probably because of the formation of hydroxyl radicals.(ABSTRACT TRUNCATED AT 250 WORDS)
在本研究中,我们调查了氧衍生自由基和铁在介导缺血再灌注期间心肌损伤中的作用。铁备受关注,因为它可能通过催化高反应性羟基自由基的形成(通过改良的哈伯-维伊斯或芬顿反应)来加重缺血再灌注期间的组织损伤。采用Langendorff法灌注的大鼠心脏经历全心缺血(37℃下15分钟)和再灌注。研究了两种铁螯合剂1,2-二甲基-3-羟基-4-吡啶酮(L1)和5-羟基-2-羟甲基-4-吡喃酮(曲酸)以及一种抗氧化剂(+)-氰基丹酚-3对收缩功能、冠状动脉血流、乳酸脱氢酶释放和乳酸生成的影响。这些铁螯合剂的组合尤为重要,因为与曲酸不同,已知L1可防止微粒体中由ADP/Fe3+和NADPH诱导的脂质过氧化。我们发现,在再灌注期间,50微摩尔L1和20微摩尔(+)-氰基丹酚-3对收缩功能(心尖位移)有显著保护作用(p<0.01,n=6),而50微摩尔曲酸则无保护作用(n=6)。再灌注期间乳酸脱氢酶释放的测量结果显示出与心脏收缩功能相似的保护模式,尽管50微摩尔曲酸在再灌注的前10分钟也显示出显著较低的乳酸脱氢酶释放。各实验组之间在冠状动脉阻力或乳酸释放方面未发现差异。我们的研究结果表明,铁和氧衍生自由基在缺血后再灌注损伤的发病机制中很重要,可能是由于羟基自由基的形成。(摘要截断于250字)